Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The main purpose of the study is to evaluate participant satisfaction after administration of ocrelizumab subcutaneous (SC) after 12 months using the therapy administration satisfaction questionnaire subcutaneous (TASQ-SC).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Ocrelizumab | Participants who are receiving ocrelizumab, SC injection, for the first time as part of their routine MS therapy at physician's discretion in accordance with local clinical practice and/or labeling will be observed for treatment satisfaction with SC injection for up to 12 months. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Ocrelizumab | Drug | Ocrelizumab will be administered as SC injection as per discretion of the treating physician in accordance with local clinical practice and local labeling. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants Their Level of by Satisfaction With Ocrelizumab SC After 12 Months Assessed Using TASQ-SC | TASQ-SC is a 12-item, participant-reported questionnaire measuring the impact of treatment administration on five domains: Physical Impact, Psychological Impact, Impact on Activities of Daily Living, Convenience, and Satisfaction. Each of the domain/scale scores is scored on a scale of 1-100, where higher scores indicate higher overall satisfaction with the therapy. | Month 12 |
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants by Their Level of Satisfaction With Ocrelizumab SC After the First Injection and After 6 Months Assessed Using TASQ-SC | TASQ-SC is a 12-item, participant-reported questionnaire measuring the impact of treatment administration on five domains: Physical Impact, Psychological Impact, Impact on Activities of Daily Living, Convenience, and Satisfaction. Each of the domain/scale scores is scored on a scale of 1-100, where higher scores indicate higher overall satisfaction with the therapy. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Participants with relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS), diagnosed according to McDonald criteria of 2017, and treated with ocrelizumab SC for the first time during routine clinical practice will be observed in this study.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Reference Study ID Number: ML45551 https://forpatients.roche.com/ | Contact | 888-662-6728 (U.S. Only) | global-roche-genentech-trials@gene.com |
| Name | Affiliation | Role |
|---|---|---|
| Clinical Trials | Hoffmann-La Roche | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Uniklinik RWTH Aachen | Recruiting | Aachen | 52074 | Germany | ||
| Gesundheitszentrum St. Marien GmbH |
For eligible studies, qualified researchers may request access to individual patient level clinical data. See Roche's commitment to transparency of clinical study information here: https://go.roche.com/data\_sharing
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Baseline, Month 6 |
| Change From Baseline in NfL Protein Levels in Serum | Month 6, Month 12 |
| Concentration of NfL Protein Levels in Serum | Baseline, Month 6, Month 12 |
| Correlation Between NfL Protein Levels in Serum With MS Relapse | The changes in levels of NfL protein levels in serum and its correlation with MS relapse will be analyzed using Pearson or Spearman correlation coefficients. | Up to Month 12 |
| Correlation Between NfL Protein Levels in Serum With Expanded Disability Status Scale (EDSS) | The changes in levels of NfL protein levels in serum and its correlation with EDSS will be analyzed using Pearson or Spearman correlation coefficients. EDSS is a scale for assessing neurologic impairment in MS. Values are from 0 points (normal neurological examination) up to 10 points (death), increasing in increments of 0.5 points. Higher scores represent increased disability. | Up to Month 12 |
| Correlation Between NfL Protein Levels in Serum With Previous MS Disease Modifying Therapy (DMT) | The changes in levels of NfL protein in serum and its correlation with DMT will be analyzed using Pearson or Spearman correlation coefficients. | Up to Month 12 |
| Correlation Between NfL Protein Levels in Serum With NfL Confounder - Serum Creatinine | The changes in levels of NfL protein in serum and its correlation with serum creatinine will be analyzed using Pearson or Spearman correlation coefficients. | Up to Month 12 |
| Correlation Between NfL Protein Levels in Serum With NfL Confounder - Co-morbidities | The changes in levels of NfL protein in serum and its correlation with co-morbidities will be analyzed using Pearson or Spearman correlation coefficients. | Up to Month 12 |
| Correlation Between NfL Protein Levels in Serum With NfL Confounder - Age | The changes in levels of NfL protein in serum and its correlation with age will be analyzed using Pearson or Spearman correlation coefficients. | Up to Month 12 |
| Correlation Between NfL Protein Levels in Serum With NfL Confounder - Body Mass Index [BMI] | The changes in levels of NfL protein in serum and its correlation with BMI will be analyzed using Pearson or Spearman correlation coefficients. | Up to Month 12 |
| Correlation Between NfL Protein Levels in Serum With Magnetic Resonance Imaging (MRI) Lesion Count | The changes in levels of NfL protein in serum and its correlation with MRI lesion count will be analyzed using Pearson or Spearman correlation coefficients. | Up to Month 12 |
| Correlation Between NfL Protein Levels in Serum With Glial Fibrillary Acidic Protein (GFAP) Levels | The changes in levels of NfL protein in serum and its correlation with GFAP levels will be analyzed using Pearson or Spearman correlation coefficients. | Up to Month 12 |
| Correlation Between NfL Protein Levels in Serum With No Evidence of Disease Activity-3 (NEDA-3) | NEDA-3 is defined by no confirmed MS relapse, no new or enlarging T2 lesions, no Gadolinium-positive T1 lesions, and no six-month confirmed disability worsening. The changes in levels of NfL protein in serum and its correlation with NEDA-3 will be analyzed using Pearson or Spearman correlation coefficients. | Up to Month 12 |
| Change From Baseline in Participant Satisfaction With Ocrelizumab SC Assessed Using Treatment Satisfaction Questionnaire for Medication (TSQM) 1.4 | TSQM version 1.4 is a 14-item questionnaire used to measure level of satisfaction or dissatisfaction with the medication on 4 domains: Effectiveness, Side Effects, Convenience, and Global Satisfaction. Each of the domain is scored on likert-type scales of 5 or 7 points ranging from 1 (least satisfied) to 5 or 7 (most satisfied). Item scores are summarized to give four domain scores, which are in turn transformed to a scale of 0-100. Higher scores indicate higher overall satisfaction with the therapy. | Month 6, Month 12 |
| Number of Participants by Their Level of Satisfaction With Ocrelizumab SC Assessed by Physician Survey | Baseline, Month 6, Month 12 |
| Annualized Relapse Rate | Month 12 |
| Percentage of Participants With Progression Independent of Relapse Activity (PIRA) | Up to Month 12 |
| Number of Participants With Non-serious Adverse Events (nsAEs), Serious Adverse Events (SAEs) and Adverse Events of Special Interests (AESIs) | Up to Month 12 |
| Recruiting |
| Amberg |
| 92224 |
| Germany |
| Sächsisches Krankenhaus Arnsdorf | Recruiting | Arnsdorf | 01477 | Germany |
| Neuropraxis im Stadtpalais Dres. Ulzheimer/Herröder/Wessig GbR | Recruiting | Aschaffenburg | 63739 | Germany |
| Neurologie Bad Soden | Recruiting | Bad Soden | 65812 | Germany |
| Neurologische Praxis - Kallmann Neurologie - mszb | Recruiting | Bamberg | 96052 | Germany |
| Marianne-Strauß-klinik | Recruiting | Berg | 82335 | Germany |
| Neurologisches Facharztzentrum Berlin am Sankt Gertrauden-Krankenhaus | Recruiting | Berlin | 10713 | Germany |
| NEUROZENTRUM tempelhof.berlin | Recruiting | Berlin | 12099 | Germany |
| Praxis Dr. Said Masri | Recruiting | Berlin | 12099 | Germany |
| Jüdisches Krankenhaus Berlin | Recruiting | Berlin | 13347 | Germany |
| NeuroZentrum Zehlendorf Dr. Ringel und Dr. Scherer | Recruiting | Berlin | 14169 | Germany |
| Neurologisches Zentrum für Bewegungsstörungen und Diagnostik | Recruiting | Berlin | 14195 | Germany |
| St. Josef-Hospital | Recruiting | Bochum | 44791 | Germany |
| Dres. Lippert/Kausch | Recruiting | Bogen | 94327 | Germany |
| Krankenhaus Buchholz Abt. Neurologie | Withdrawn | Buchholz | 21244 | Germany |
| Allgemeines Krankenhaus Celle / Klinik für Neurologie | Recruiting | Celle | 29223 | Germany |
| Neuropraxis Celle: Praxis für Neurologie & Psychatrie | Recruiting | Celle | 29223 | Germany |
| Praxisgemeinschaft Dres. Sylke Domke und Vasil Gjaurov | Recruiting | Chemnitz | 09117 | Germany |
| NeuroMed Campus Neurologische Gemeinschaftspraxis am St. Elisabeth Krankenhaus | Recruiting | Cologne | 50935 | Germany |
| Gemeinschaftspraxis Dr. med. Josef Leclaire und Dr. med. Thomas Rotermund | Withdrawn | Dortmund | 44137 | Germany |
| Gemeinschaftspraxis für Neurologie | Recruiting | Düsseldorf | 40211 | Germany |
| Universitätsklinikum Düsseldorf | Recruiting | Düsseldorf | 40225 | Germany |
| Nervenarztpraxis Gerresheim | Recruiting | Düsseldorf | 40625 | Germany |
| Gemeinschaftspraxis für Neurologie und Psychiatrie, Psychotherapie | Recruiting | Eltville | 65343 | Germany |
| NeuroCentrum Odenwald | Recruiting | Erbach/Odenwald | 64711 | Germany |
| Universitätsklinikum Erlangen, Neurologische Klinik | Recruiting | Erlangen | 91054 | Germany |
| Zentrum für ambulante Neurologie / Praxis Knorn Landefeld Friedrich | Recruiting | Essen | 45138 | Germany |
| Praxis Nervenstark | Recruiting | Essen | 45257 | Germany |
| Praxis für Neurologie, Nervenheilkunde & Neurochirurgie | Completed | Forchheim | 91301 | Germany |
| Klinikum Joh.Wolfg.Goethe-UNI Senckenbergisches Institut für Neuroonkologie | Recruiting | Frankfurt | 60528 | Germany |
| Varisano Klinikum Frankfurt Höchst GmbH | Recruiting | Frankfurt | 65929 | Germany |
| Universitätsklinikum Freiburg, Klinik für Neurologie und Neurophysiologie | Recruiting | Freiburg im Breisgau | 79106 | Germany |
| Praxis im Bahnhof | Recruiting | Füssen | 87629 | Germany |
| Universitätsklinikum Gießen und Marburg GmbH | Recruiting | Giessen | 35392 | Germany |
| Neurologie & Psychiatrie Gladenbach - MS-Zentrum | Recruiting | Gladenbach | 35075 | Germany |
| MVZ Bezirkskliniken Schwaben, Standort Günzburg | Recruiting | Günzburg | 89312 | Germany |
| Krankenhaus Martha-Maria Halle-Doelau | Recruiting | Halle | 06120 | Germany |
| Universiätsklinikum Hamburg-Eppendorf | Recruiting | Hamburg | 20246 | Germany |
| Neurologische Praxis Eppendorf | Recruiting | Hamburg | 20249 | Germany |
| Neurologische Praxis | Recruiting | Hanover | 30171 | Germany |
| Oberhavel Kliniken GmbH, Klinik Hennigsdorf, Neurologie | Recruiting | Hennigsdorf | 16761 | Germany |
| Praxis Dr. Hospely | Recruiting | Herford | 32052 | Germany |
| Haus- und Facharztzentrum Laucherttal / Alb | Recruiting | Hettingen | 72513 | Germany |
| Klinikum Ibbenbüren gmbH | Recruiting | Ibbenbueren | 49477 | Germany |
| Augustahospital Anholt;Neurologie | Recruiting | Isselburg | 46419 | Germany |
| Universitätsklinikum Jena, Klinik für Neurologie | Recruiting | Jena | 07747 | Germany |
| Uniklinik Schleswig-Holstein | Recruiting | Kiel | 24105 | Germany |
| Arztpraxis Dr. med. Torsten Sühnel | Recruiting | Leipzig | 04299 | Germany |
| Neurologische Praxis Dr. Ehrlich | Recruiting | Leipzig | 04315 | Germany |
| Neurologie im Ulrichshaus Magdeburg | Recruiting | Magdeburg | 39104 | Germany |
| Universitätsklinikum Magdeburg | Recruiting | Magdeburg | 39120 | Germany |
| Neuroplus Dres. Lennart Thilmann/ Patrick Thilmann | Recruiting | Mannheim | 68163 | Germany |
| Universitätsklinikum Mannheim | Recruiting | Mannheim | 68167 | Germany |
| Universitätsklinikum Giessen und Marburg | Recruiting | Marburg | 35043 | Germany |
| Praxis Dr. Leussink | Recruiting | Meerbusch | 40667 | Germany |
| Neurologie am Preußenmuseum | Recruiting | Minden | 32423 | Germany |
| Neurologie München Nord | Recruiting | München | 80939 | Germany |
| Klinikum rechts der Isar der TU München | Recruiting | München | 81675 | Germany |
| Praxis für Neurologie und Psychiatrie am Prinzregentenplatz | Recruiting | München | 81675 | Germany |
| Herz-Jesu-Krankenhaus Hiltrup GmbH | Recruiting | Münster | 48165 | Germany |
| Neurologisch-psychiatrische Praxis im A4 | Recruiting | Neu-Ulm | 89231 | Germany |
| Praxis Dr. med. Bergmann | Recruiting | Neuburg am Inn | 86633 | Germany |
| Gemeinschaftspraxis Uhlig und Windsheimer | Recruiting | Nuremberg | 90419 | Germany |
| Neurologie Nürnberg-Eibach | Recruiting | Nuremberg | 90451 | Germany |
| Neurologie an der Hase | Recruiting | Osnabrück | 49074 | Germany |
| Dres. Beckmann / Schlüter | Recruiting | Öhringen | 74613 | Germany |
| Facharztpraxis für Neurologie und Psychiatrie Dres Mattes/Stockert | Recruiting | Pforzheim | 75172 | Germany |
| Neurologisches Studienzentrum Artland | Recruiting | Quakenbrück | 49610 | Germany |
| Gemeinschaftspraxis für Neurologie | Recruiting | Regensburg | 93059 | Germany |
| Praxis Dr. Stienker-Fisse | Recruiting | Remscheid | 42853 | Germany |
| ZNS Südpfalz | Recruiting | Rülzheim | 76761 | Germany |
| Neurologische Praxis Dr. Wagner | Recruiting | Schwetzingen | 68723 | Germany |
| Gemeinschaftspraxis für Neurologie, Psychiatrie und Psychotherapie | Recruiting | Siegen | 57072 | Germany |
| Praxis für Neurologie und Psychiatrie | Recruiting | Siegen | 57076 | Germany |
| EMSA - Zentrum für Neurologie?/?Psychiatrie?/?Neuroradiologie | Recruiting | Singen | 78224 | Germany |
| Praxis Dr. med. Max Deist und Michael Ernst ?Sinsheim | Recruiting | Sinsheim | 74889 | Germany |
| Gemeinschaftspraxis Dr. Wolfram von Pannwitz, MBA & Dr. med. Marie Perle Brinckmann | Recruiting | Steglitz | 12163 | Germany |
| Praxis Dr. med. Andreas Kowalik, Arzt für Neurologie und Psychiatrie | Recruiting | Stuttgart | 70174 | Germany |
| Neuropraxis Sotiriadis | Recruiting | Stuttgart | 70176 | Germany |
| Neurozentrum Stuttgart Mitte Sophienstraße | Recruiting | Stuttgart | 70178 | Germany |
| Sauerlandklinik Hachen | Recruiting | Sundern | 59846 | Germany |
| Universitätsklinikum Tübingen, Zentrum für Neurologie | Recruiting | Tübingen | 72076 | Germany |
| Nervenfachaerztliche Gemeinschaftspraxis Ulm | Recruiting | Ulm | 89078 | Germany |
| Neuropraxis München Süd | Recruiting | Unterhaching | 82008 | Germany |
| Praxis für Neurologie, Psychiatrie und Epileptologie | Recruiting | Weil der Stadt | 71263 | Germany |
| Praxis Dr. Michaela Krause | Recruiting | Wolfratshausen | 82515 | Germany |
| Heinrich-Braun-Krankenhaus Städtisches Klinikum | Recruiting | Zwickau | 08060 | Germany |
| Inselspital-Universitaetsspital Bern | Recruiting | Bern | 3010 | Switzerland |
| Bellevue Medical Grop AG | Recruiting | Zurich | 8001 | Switzerland |
| ID | Term |
|---|---|
| D009103 | Multiple Sclerosis |
| ID | Term |
|---|---|
| D020278 | Demyelinating Autoimmune Diseases, CNS |
| D020274 | Autoimmune Diseases of the Nervous System |
| D009422 | Nervous System Diseases |
| D003711 | Demyelinating Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C533411 | ocrelizumab |
Not provided
Not provided
Not provided